Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Pharmadrug (BUZZ)

Pharmadrug Inc
Date:
Sort by:
 Showing the most relevant articles for your search:CSE:BUZZ
DateTimeSourceHeadlineSymbolCompany
20/04/202113:41InvestorsHub NewsWirePHARMADRUG ADVANCES PRODUCT AND CLINICAL DEVELOPMENT OF CEPHARANTHINE TO TREAT RARE CANCERS AND INFECTIOUS DISEASESCSE:BUZZPharmadrug Inc
16/03/202112:10InvestorsHub NewsWirePHARMADRUG INITIATES DMT RESEARCH ACTIVITIES VIA COLLABORATION WITH THE UNIVERSITY OF MICHIGAN FOR FOUNDATIONAL DMT RESEARCHCSE:BUZZPharmadrug Inc
25/02/202113:13InvestorsHub NewsWirePHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN KIDNEY TRANSPLANTATION AND EXPANDS ON ITS PSYCHEDELICS STRATEGYCSE:BUZZPharmadrug Inc
11/02/202113:18InvestorsHub NewsWirePHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN STROKECSE:BUZZPharmadrug Inc
08/02/202113:00InvestorsHub NewsWirePHARMADRUG APPOINTS WORLD-RENOWNED DMT EXPERT DR. STEVEN A. BARKER TO ITS SCIENTIFIC ADVISORY BOARD...ContCSE:BUZZPharmadrug Inc
04/02/202113:58InvestorsHub NewsWirePHARMADRUG SIGNS SUPPLY AGREEMENT WITH GLOBAL CANNABIS SUPPLIER AND PROVIDES UPDATE ON GERMAN OPERATIONSCSE:BUZZPharmadrug Inc
02/02/202113:48InvestorsHub NewsWirePHARMADRUG COMPLETES ACQUISITION OF SAIRIYO THERAPEUTICS INC.CSE:BUZZPharmadrug Inc
25/01/202114:01InvestorsHub NewsWirePHARMADRUG ENTERS DEFINITIVE AGREEMENT FOR ACQUISITION OF SAIRIYO THERAPEUTICS INC.CSE:BUZZPharmadrug Inc
12/01/202113:40InvestorsHub NewsWirePHARMADRUG ANNOUNCES LOI TO ACQUIRE SAIRIYO THERAPEUTICS INCCSE:BUZZPharmadrug Inc
 Showing the most relevant articles for your search:CSE:BUZZ